HYTENZA CO

This brand name is authorized in South Africa.

Active ingredients

The drug HYTENZA CO contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Losartan UNII `3ST302B24A` - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT₁) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan
`2`	Hydrochlorothiazide UNII `0J48LPH2TH` - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DA01	Losartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ZA	Health Products Regulatory Authority	43/7.1.3/0807

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.